Готові списки джерел за темами / Diagnosis/Therapy

Зміст

  1. Статті в журналах
  2. Дисертації
  3. Книги
  4. Частини книг
  5. Тези доповідей конференцій
  6. Звіти організацій

Добірка наукової літератури з теми "Diagnosis/Therapy"

Автор: Grafiati
Опубліковано: 20 квітня 2024

Оформте джерело за APA, MLA, Chicago, Harvard та іншими стилями

Оберіть тип джерела:

Ознайомтеся зі списками актуальних статей, книг, дисертацій, тез та інших наукових джерел на тему "Diagnosis/Therapy".

Біля кожної праці в переліку літератури доступна кнопка «Додати до бібліографії». Скористайтеся нею – і ми автоматично оформимо бібліографічне посилання на обрану працю в потрібному вам стилі цитування: APA, MLA, «Гарвард», «Чикаго», «Ванкувер» тощо.

Також ви можете завантажити повний текст наукової публікації у форматі «.pdf» та прочитати онлайн анотацію до роботи, якщо відповідні параметри наявні в метаданих.

Статті в журналах з теми "Diagnosis/Therapy"

1

Adamski, Adam. "Diagnosis and Therapy of an Autistic Child." Biomedical Research and Clinical Reviews 3, no. 5 (April 19, 2021): 01–11. http://dx.doi.org/10.31579/2692-9406/045.

Повний текст джерела
Анотація:
Knowledge of autism is growing tremendously, since the first formulation of the phenomenon of autism in 1943, there is still no cure for the cure of changes in the brain that create the symptoms of autism. I still find better ways of understanding the disease and help patients adapt, but does not give a full understanding of what autism. There are different types of therapy in the field of speech, behavior, vision, hearing, as well as drugs and dietary recommendations, but they are often ineffective. Treatments should be tailored to the individual needs of the patient. The author of that work will pay attention to corrective therapy movement, and the mechanism of imitation, these two factors in autism do not exhibit synchronization, because the child did not received during the birth. Autistic children from the area have movement disorders, and the lack of a mechanism to follow. My research results confirm the view that the movement disorder and the mechanism of imitation are inherent in the phenomenon of autism. The study of movement disorders in children, and the mechanism of imitation, may serve as an early indicator of autism diagnosis methods. They point to the need for the development of therapies to be used from the first months of life in autism.
Стилі APA, Harvard, Vancouver, ISO та ін.
2

Sonnenberg, Amnon. "Therapy Without Diagnosis." American Journal of Gastroenterology 109, no. 11 (November 2014): 1837–38. http://dx.doi.org/10.1038/ajg.2014.291.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
3

BERNAYS, ME. "Diagnosis and therapy." Australian Veterinary Journal 76, no. 5 (May 1998): 316. http://dx.doi.org/10.1111/j.1751-0813.1998.tb12352.x.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
4

SMITH, JS. "Diagnosis and therapy." Australian Veterinary Journal 77, no. 9 (September 1999): 566. http://dx.doi.org/10.1111/j.1751-0813.1999.tb13189.x.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
5

Zimny, Nancy J., Catherine C. Goodman, and Marianne Orest. "Physical Therapy Diagnosis." Physical Therapy 75, no. 7 (July 1, 1995): 635–38. http://dx.doi.org/10.1093/ptj/75.7.635.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
6

Branch, Lionel Andrew. "Timely therapy requires timely diagnosis; high risk therapy demands accurate diagnosis." Journal of the Neurological Sciences 382 (November 2017): 155–56. http://dx.doi.org/10.1016/j.jns.2017.07.023.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
7

Bortelová, Karolína. "Vitiligo: diagnosis and therapy." Dermatologie pro praxi 13, no. 2 (June 10, 2019): 72–75. http://dx.doi.org/10.36290/der.2019.011.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
8

Yunusovа, E. I. "Keratoacanthoma: clinic, diagnosis, therapy." Dalʹnevostočnyj medicinskij žurnal, no. 2 (June 25, 2021): 78–81. http://dx.doi.org/10.35177/1994-5191-2021-2-78-81.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
9

Williamson, R. Anthony. "Prions: conformations, diagnosis, therapy." Biochemical Society Transactions 30, no. 3 (June 1, 2002): A67. http://dx.doi.org/10.1042/bst030a067c.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
10

Moore, Patricia. "Vasculitis: Diagnosis and Therapy." Seminars in Neurology 14, no. 02 (June 1994): 159–67. http://dx.doi.org/10.1055/s-2008-1041074.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
Більше джерел

Дисертації з теми "Diagnosis/Therapy"

1

Enomoto, Dorathy Ngauwlieng Hendrikje. "Scleroderma: diagnosis and experimental therapy." [S.l. : Amsterdam : s.n.] ; Universiteit van Amsterdam [Host], 2000. http://dare.uva.nl/document/57061.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
2

Marti, Pamela. "New perspectives for allergy diagnosis and therapy /." [S.l.] : [s.n.], 2005. http://www.zb.unibe.ch/download/eldiss/06marti_p.pdf.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
3

Jolley, Clive Joseph. "Radiolabelling of antibodies for tumour diagnosis and therapy." Thesis, University of Kent, 1993. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.334038.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
4

May, Stephen J. "Development of aspects of mechanical diagnosis and therapy." Thesis, Sheffield Hallam University, 2009. http://shura.shu.ac.uk/20757/.

Повний текст джерела
Анотація:
Mechanical Diagnosis and Therapy is a system of classification, assessment and management applied to all musculoskeletal problems that is used by clinicians worldwide. The first section concerns the up-dating and contextualising of Mechanical Diagnosis and Therapy (MDT). The books, co-authored with the founder of MDT, Robin McKenzie, applied the principles to extremity musculoskeletal problems, and then set MDT in the contemporary evidence-based background for lumbar, cervical and thoracic problems. This involved an up-dating of the classification system, as well as synthesis and analysis of aspects of musculoskeletal medicine. The second section presents a patient perspective on musculoskeletal problems. This involves an exploration of patient opinions about back pain and its management, and an audit of outcomes in a clinical setting in which an active exercise-based treatment approach was applied. The third section relates to a number of publications that sought to validate aspects of MDT. Centralisation is a key finding during the assessment of spinal patients and work on this included a systematic review of the relevant literature and an analysis of centralisation in patients with sciatica. In another study we conducted a secondary analysis of a published trial to see what happened if patients were crossed-over from exercises that were unmatched with directional preference to matched exercises. We published a case-control study that validates the postural syndrome and measured the prevalence rates of MDT classifications in the patient population. Reliability is a keycomponent of any musculoskeletal assessment system in which clinicians are making management decisions based on physical examination procedures - a systematic review that detailed the reliability of MDT compared to other commonly used examination procedures was an important contribution to the literature. Overall these works have led to a significant independent and original contribution to knowledge and understanding of MDT.
Стилі APA, Harvard, Vancouver, ISO та ін.
5

Tse, Tsz Ho. "Medical robots for MRI guided diagnosis and therapy." Thesis, Imperial College London, 2009. http://hdl.handle.net/10044/1/5643.

Повний текст джерела
Анотація:
Magnetic Resonance Imaging (MRI) provides the capability of imaging tissue with fine resolution and superior soft tissue contrast, when compared with conventional ultrasound and CT imaging, which makes it an important tool for clinicians to perform more accurate diagnosis and image guided therapy. Medical robotic devices combining the high resolution anatomical images with real-time navigation, are ideal for precise and repeatable interventions. Despite these advantages, the MR environment imposes constraints on mechatronic devices operating within it. This thesis presents a study on the design and development of robotic systems for particular MR interventions, in which the issue of testing the MR compatibility of mechatronic components, actuation control, kinematics and workspace analysis, and mechanical and electrical design of the robot have been investigated. Two types of robotic systems have therefore been developed and evaluated along the above aspects. (i) A device for MR guided transrectal prostate biopsy: The system was designed from components which are proven to be MR compatible, actuated by pneumatic motors and ultrasonic motors, and tracked by optical position sensors and ducial markers. Clinical trials have been performed with the device on three patients, and the results reported have demonstrated its capability to perform needle positioning under MR guidance, with a procedure time of around 40mins and with no compromised image quality, which achieved our system speci cations. (ii) Limb positioning devices to facilitate the magic angle effect for diagnosis of tendinous injuries: Two systems were designed particularly for lower and upper limb positioning, which are actuated and tracked by the similar methods as the first device. A group of volunteers were recruited to conduct tests to verify the functionality of the systems. The results demonstrate the clear enhancement of the image quality with an increase in signal intensity up to 24 times in the tendon tissue caused by the magic angle effect, showing the feasibility of the proposed devices to be applied in clinical diagnosis.
Стилі APA, Harvard, Vancouver, ISO та ін.
6

COX, ALYSIA SARAH-MARIE. "Nanoparticles for Therapy and Diagnosis of Neurodegenerative Diseases." Doctoral thesis, Università degli Studi di Milano-Bicocca, 2019. http://hdl.handle.net/10281/241331.

Повний текст джерела
Анотація:
Nanoparticles (NPs) are studied as a promising tool to efficiently deliver drugs across biological barriers, which can hinder effective pharmacological treatment for a variety of diseases. One of the key issues to evaluate is the corona, a layer of proteins attached to the surface, formed upon contact of NPs with biological fluids. It is well known that the corona affects bioavailability, toxicity and clearance of NPs. Though the corona is relatively well defined under various conditions, its evolution when it crosses biological barriers was unknown. In my research I utilized gold NPs and a transwell cellular model of the BBB (human brain endothelial cells - hCMEC/D3) to investigate this issue. The protein composition of the corona across the “brain” and “blood” compartments was qualitatively and semi-quantitatively analyzed using SDS-PAGE and MS. The protein corona changed dramatically following passage through the BBB, since many proteins were removed, and 15 out of 381 were enriched in the “brain” side compared to the “blood” side, including alpha-2-macroglobulin and fetuin A. This clearly indicates the dynamic nature of the corona, and the ability or inability of specific proteins bound to NPs to traverse the BBB. The research also established that NP corona in the basolateral side is actually an evolution of the one formed on the apical side ruling out that it is formed in situ by interaction with proteins arriving independently from the apical side. Once beyond the barrier, the corona was stable upon incubation with other proteins Proteins that were enriched upon passage were used to functionalize NPs, demonstrating their ability to boost passage through the BBB and suggesting that physiological proteins could help to more effectively deliver drugs to the central nervous system. Altogether, these results are particularly relevant when developing NPs that are required to traverse any biological barrier and may lead to the more successful design of therapeutic and/or diagnostic nanodevices.
Nanoparticles (NPs) are studied as a promising tool to efficiently deliver drugs across biological barriers, which can hinder effective pharmacological treatment for a variety of diseases. One of the key issues to evaluate is the corona, a layer of proteins attached to the surface, formed upon contact of NPs with biological fluids. It is well known that the corona affects bioavailability, toxicity and clearance of NPs. Though the corona is relatively well defined under various conditions, its evolution when it crosses biological barriers was unknown. In my research I utilized gold NPs and a transwell cellular model of the BBB (human brain endothelial cells - hCMEC/D3) to investigate this issue. The protein composition of the corona across the “brain” and “blood” compartments was qualitatively and semi-quantitatively analyzed using SDS-PAGE and MS. The protein corona changed dramatically following passage through the BBB, since many proteins were removed, and 15 out of 381 were enriched in the “brain” side compared to the “blood” side, including alpha-2-macroglobulin and fetuin A. This clearly indicates the dynamic nature of the corona, and the ability or inability of specific proteins bound to NPs to traverse the BBB. The research also established that NP corona in the basolateral side is actually an evolution of the one formed on the apical side ruling out that it is formed in situ by interaction with proteins arriving independently from the apical side. Once beyond the barrier, the corona was stable upon incubation with other proteins Proteins that were enriched upon passage were used to functionalize NPs, demonstrating their ability to boost passage through the BBB and suggesting that physiological proteins could help to more effectively deliver drugs to the central nervous system. Altogether, these results are particularly relevant when developing NPs that are required to traverse any biological barrier and may lead to the more successful design of therapeutic and/or diagnostic nanodevices.
Стилі APA, Harvard, Vancouver, ISO та ін.
7

Sulé-Suso, Josep. "Autologous cell approaches to diagnosis and therapy in oncology." Thesis, Keele University, 2002. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.252570.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
8

Baillie-Hamilton, Paula. "Applications of magnetic resonance in cancer diagnosis and therapy." Thesis, University of Oxford, 1995. http://ora.ox.ac.uk/objects/uuid:72d25d7c-4f5a-4bc4-9fb0-45f758c09d7b.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
9

Wang, Xueli. "Organic molecules for diagnosis and therapy of Alzheimer's disease." HKBU Institutional Repository, 2020. https://repository.hkbu.edu.hk/etd_oa/883.

Повний текст джерела
Анотація:
Alzheimer's disease has become one of the most common diseases jeopardizing the health of the human being. The main pathological feature of AD is the accumulation of Aβ in the brain to form senile plaques. Therefore, it is of great significance to develop new and efficient drugs targeting at amyloid-β for the detection, diagnosis and therapeutics for Alzheimer's disease. Xanthohumol (Xn) naturally presents in hops (Humulus lupulus L). Studies have shown that it has anti-lipoperoxidative, anti-inflammatory, anti-proliferative activities, antiangiogenic and antioxidant effects, which further illustrates its potential therapeutic for AD. However, the bio-incompatibility and blood-brain barrier impermeability of Xanthohumol hindered it in vivo efficacy potential for treating Alzheimer's disease. Thus, we designed and prepared a series of Xanthohumol derivatives, namely, Xn-n, (n = 1-9) and its chalcone derivatives C-n, (n = 1-10) to enhance the desirable physical, biological and pharmacological properties, especially the blood-brain barrier permeability for intervention of AD. As an effective technique for in vivo visualization, Near-infrared fluorescence imaging based on organic small molecule probes has a promising application in the diagnosis of Alzheimer's disease. However, most of the reported imaging probes can only visualize Aβ-plaques but do not have therapeutic potential such as neuroprotection against Aβ induced toxicity. Herein, we designed and synthesized a series of oligomeric Aβ targeted near infrared (NIR) fluorescent probes for the diagnosis and therapeutics of Alzheimer's disease, namely DBAN-SLM, DBAN-SLOH, DBAN-OSLM which showed remarkably effective inhibitory effect on Aβ aggregation, significant neuroprotection effect against the Aβ-induced toxicities, and suppression on Aβ-induced ROS generation. indicating its great promise as a useful theragnostic agent for the early diagnosis and therapy of AD. Dual-modal imaging is an important approach to overcome the limitations of single imaging technology in the diagnosis of AD disease. Therefore, based on the dual-modal, we designed and synthesized the NIR/MR dual-modal detection and theragnostic probes namely Dyad-1, Dyad-2, Dyad-3 and NP@SiO2@F-SLOH. More surprising is that the two NIR/MR dual-modal probes show excellent biological properties, including the ability to inhibit Aβ aggregation to a certain extent, neuroprotective effects on cytotoxicity caused by different forms of Aβ species, blood-brain barrier (BBB) permeability, and high stability. All of these newly designed and synthesized molecules were characterized with 1H NMR, 13C NMR, and HRMS and found to show good agreement with the desired structures. The photophysical properties and biological properties of these novel designed and synthesized fluorescent probe such as UV-vis absorption, fluorescence emission, dissociation constant determined by fluorescence titration, cytotoxicity assay, neuroprotection, and inhibition of Aβ aggregation were investigated
Стилі APA, Harvard, Vancouver, ISO та ін.
10

Hembury, Mathew Thomas. "Gold-silica quantum rattles for cancer therapy and diagnosis." Thesis, Imperial College London, 2013. http://hdl.handle.net/10044/1/14493.

Повний текст джерела
Анотація:
The Holy Grail of cancer research is to find effective treatments that can be easily delivered to diseased cells with minimal collateral damage to healthy tissue. In this context, recent developments in nanoparticle technology have aroused considerable interest with the promise of multifunctional vectors for both diagnostic and treatment of cancer. Recently, new emphasis has been placed on hybrid nanoparticle (NP) systems, where combinations of different types of nanostructured materials are used to create multimodal systems that exhibit the combined beneficial properties of the component modules. In particular, nanorattles, which are NPs with a core-shell structure containing a distinctive void separating the core material from the shell, constitute promising launch platforms for many biomedical applications. Current hybrid NP systems tend to concentrate on adding extra properties by increasing the number of modules and therefore, system complexity. However, added complexity in itself does not guarantee higher effectiveness. Therefore, in this thesis, a more holistic approach is proposed whereby simplicity, efficiency and usefulness of the design are not overlooked. The work presented here describes a gold-silica rattle-type particle, the Quantum Rattle (QR), made of a hollow mesoporous silica shell (HS) hosting two classes of hydrophobic gold nanostructures: gold quantum dots (AuQDs) and gold nanoparticles (AuNPs). The HS stabilises the gold nanostructures, making them dispersible in water and thereby enables biomedical applications. It also allows passive targeting for the QR via the enhanced permeability and retention (EPR) effect. The AuQDs absorb and emit light in the near-infrared (NIR) biological window where blood and soft tissue are relatively transparent (650 nm - 900 nm). With their NIR photonics, the AuQDs mediate both photothermal therapy (PPT) and live infrared imaging. Finally, the hydrophobic AuNPs optimise the system’s drug carrying performance by increasing the payload’s loading efficiency as well as controlling its release profile. This thesis exhibits the first evidence of the intrinsic and efficient therapeutic and diagnostic potential of this new class of hybrid NP system and discusses how these results could have a significant impact on the growing field of nanosystems used for cancer treatment.
Стилі APA, Harvard, Vancouver, ISO та ін.
Більше джерел

Книги з теми "Diagnosis/Therapy"

1

1947-, Stillman RichardM, ed. Surgery: Diagnosis & therapy. London: Prentice-Hall International, 1989.

Знайти повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
2

Weissleder, Horst. Lymphedema: Diagnosis and therapy. 2nd ed. Bonn: Kagerer Kommunikation, 1997.

Знайти повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
3

1937-, Stein Jay H., ed. Internal medicine: Diagnosis & therapy. 3rd ed. Norwalk, Conn: Appleton & Lange, 1993.

Знайти повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
4

Lymphedema: Diagnosis and therapy. 3rd ed. Köln: Viavital Verlag, 2001.

Знайти повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
5

Bertha, Frisch, and SpringerLink (Online service), eds. Osteoporosis: Diagnosis, Prevention, Therapy. Berlin, Heidelberg: Springer Berlin Heidelberg, 2009.

Знайти повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
6

Fetal diagnosis and therapy. Philadelphia, PA: Saunders, 1997.

Знайти повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
7

Gabriel, Khanm M. I., ed. Medical diagnosis and therapy. Philadelphia: Lea & Febiger, 1994.

Знайти повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
8

El, Aad van der. Orthopedic manual therapy diagnosis. Sudbury, Mass: Jones and Bartlett, 2010.

Знайти повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
9

Ricci, Giano. Periodontal diagnosis and therapy. Milan: Quintessenza Edizioni, 2014.

Знайти повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
10

Albert, Reece E., ed. Fetal diagnosis and therapy. Philadelphia: Saunders, 1997.

Знайти повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
Більше джерел

Частини книг з теми "Diagnosis/Therapy"

1

Brockhausen, Inka, and William Kuhns. "Diagnosis and Therapy." In Glycoproteins and Human Disease, 227–36. Berlin, Heidelberg: Springer Berlin Heidelberg, 1997. http://dx.doi.org/10.1007/978-3-662-21960-7_27.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
2

Simon, Hermann. "Diagnosis and Therapy." In True Profit!, 93–122. Cham: Springer International Publishing, 2021. http://dx.doi.org/10.1007/978-3-030-76702-0_5.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
3

Hoyt, Michael F., and Flavio Cannistrà. "Diagnosis and Brief Therapy." In Brief Therapy Conversations, 28–51. New York: Routledge, 2022. http://dx.doi.org/10.4324/9781003307709-3.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
4

Müller, Günter. "Personalized Diagnosis and Therapy." In Drug Discovery and Evaluation: Pharmacological Assays, 3167–284. Cham: Springer International Publishing, 2016. http://dx.doi.org/10.1007/978-3-319-05392-9_152.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
5

Lee, Thomas F. "Disease, Diagnosis, and Therapy." In The Human Genome Project, 183–207. Boston, MA: Springer US, 1991. http://dx.doi.org/10.1007/978-1-4899-6022-1_8.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
6

Müller, Günter. "Personalized Diagnosis and Therapy." In Drug Discovery and Evaluation: Pharmacological Assays, 1–127. Berlin, Heidelberg: Springer Berlin Heidelberg, 2015. http://dx.doi.org/10.1007/978-3-642-27728-3_152-1.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
7

Pape, Haiko, and Yu-Mi Ryang. "Osteoporosis (Etiology, Diagnosis, Drug Therapy, Surgical Therapy)." In Spine Surgery, 369–75. Cham: Springer International Publishing, 2019. http://dx.doi.org/10.1007/978-3-319-98875-7_45.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
8

Priest, Jacob B. "Systemic Diagnosis in the Therapy Room." In Systemic Diagnosis, 169–76. New York: Routledge, 2023. http://dx.doi.org/10.4324/9781003295907-13.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
9

Jacob, Sharon E., Elise M. Herro, and James S. Taylor. "Contact Dermatitis: Diagnosis and Therapy." In Textbook of Clinical Pediatrics, 1467–76. Berlin, Heidelberg: Springer Berlin Heidelberg, 2012. http://dx.doi.org/10.1007/978-3-642-02202-9_144.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
10

Bothe, Hans-Werner. "Facial Pain: Diagnosis and Therapy." In Samii's Essentials in Neurosurgery, 483–91. Berlin, Heidelberg: Springer Berlin Heidelberg, 2014. http://dx.doi.org/10.1007/978-3-642-54115-5_38.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.

Тези доповідей конференцій з теми "Diagnosis/Therapy"

1

de la Fuente, Jesus M. "Nanoactuators for Therapy and Diagnosis." In Advanced materials and devices for nanomedicine. València: Fundació Scito, 2022. http://dx.doi.org/10.29363/nanoge.amamed.2022.012.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
2

Subiel, Anna, Carlos Granja, and Claude Leroy. "Photodynamic Diagnosis and Therapy of Cancer." In NUCLEAR PHYSICS METHODS AND ACCELERATORS IN BIOLOGY AND MEDICINE: Fifth International Summer School on Nuclear Physics Methods and Accelerators in Biology and Medicine. AIP, 2010. http://dx.doi.org/10.1063/1.3295649.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
3

Chernov, V., R. Zeltchan, A. Medvedeva, I. Sinilkin, and O. Bragina. "Nuclear medicine in cancer diagnosis and therapy." In PHYSICS OF CANCER: INTERDISCIPLINARY PROBLEMS AND CLINICAL APPLICATIONS: Proceedings of the International Conference on Physics of Cancer: Interdisciplinary Problems and Clinical Applications (PC IPCA’17). Author(s), 2017. http://dx.doi.org/10.1063/1.5001593.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
4

Shtam, T., R. Samsonov, R. Kamyshinsky, R. Pantina, N. Verlov, A. Vasiliev, A. L. Konevega, and A. V. Malek. "Exosomes: Some approaches to cancer diagnosis and therapy." In PHYSICS OF CANCER: INTERDISCIPLINARY PROBLEMS AND CLINICAL APPLICATIONS: Proceedings of the International Conference on Physics of Cancer: Interdisciplinary Problems and Clinical Applications (PC IPCA’17). Author(s), 2017. http://dx.doi.org/10.1063/1.5001645.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
5

Lin, Alex W. H., Christopher H. Loo, Leon R. Hirsch, Jennifer K. Barton, Min-Ho Lee, Naomi J. Halas, Jennifer L. West, and Rebekah A. Drezek. "Nanoshells for integrated diagnosis and therapy of cancer." In Optics East, edited by M. Saif Islam and Achyut K. Dutta. SPIE, 2004. http://dx.doi.org/10.1117/12.570267.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
6

CZYŻEWSKI, A., and J. KLEJSA. "TINNITUS DIAGNOSIS AND THERAPY METHOD EMPLOYING ULTRASOUND DITHERING." In Proceedings of the Seventh International Workshop. WORLD SCIENTIFIC, 2006. http://dx.doi.org/10.1142/9789812773197_0028.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
7

Zabaneh, SI, J. Kim, G. Pierchalla, U. Schneider, K. Stölzel, and S. Dommerich. "Therapy-resistant otitis media – a rare differential diagnosis." In Abstract- und Posterband – 90. Jahresversammlung der Deutschen Gesellschaft für HNO-Heilkunde, Kopf- und Hals-Chirurgie e.V., Bonn – Digitalisierung in der HNO-Heilkunde. Georg Thieme Verlag KG, 2019. http://dx.doi.org/10.1055/s-0039-1686554.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
8

Sarkodie-Gyan, Thompson. "Optimization of diagnosis and therapy in human gait." In the Community (ICORR). IEEE, 2009. http://dx.doi.org/10.1109/icorr.2009.5209490.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
9

Sridhar, S., M. Amiji, D. Shenoy, D. Nagesha, V. Weissig, and W. Fu. "Nanomedicine: a new paradigm in diagnosis and therapy." In Optics East 2005, edited by M. Saif Islam and Achyut K. Dutta. SPIE, 2005. http://dx.doi.org/10.1117/12.634259.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
10

Haritha, K., Bethanney Janney J, M. Hemalatha, T. Sudhakar, J. Premkumar, and Aishvariya Shivani S. "Varicose Vein Diagnosis System and Therapy: A Review." In 2022 International Conference on Computer, Power and Communications (ICCPC). IEEE, 2022. http://dx.doi.org/10.1109/iccpc55978.2022.10072209.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.

Звіти організацій з теми "Diagnosis/Therapy"

1

Zhang, Hui. Use p27KIP1 Degradation for Breast Cancer Diagnosis and Therapy. Fort Belvoir, VA: Defense Technical Information Center, July 2001. http://dx.doi.org/10.21236/ada396607.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
2

Zhang, Hui. Use P27KIP1 Degradation for Breast Cancer Diagnosis and Therapy. Fort Belvoir, VA: Defense Technical Information Center, July 2002. http://dx.doi.org/10.21236/ada412764.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
3

Steven Larson MD. Cyclotron Produced Radionuclides for Diagnosis and Therapy of Human Neoplasms. Office of Scientific and Technical Information (OSTI), September 2009. http://dx.doi.org/10.2172/964282.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
4

Zhang, Hui. Use p27(KIPI) Degradation for Breast Cancer Diagnosis and Therapy. Fort Belvoir, VA: Defense Technical Information Center, July 2003. http://dx.doi.org/10.21236/ada425186.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
5

Ingber, Donald. Development of New Approaches for Breast Cancer Therapy and Diagnosis Based on Angiogenesis. Fort Belvoir, VA: Defense Technical Information Center, October 1996. http://dx.doi.org/10.21236/ada323555.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
6

Wang, Paul C. A Partnership Training Program: Studying Targeted Drug Delivery Using Nanoparticles in Breast Cancer Diagnosis and Therapy. Fort Belvoir, VA: Defense Technical Information Center, October 2014. http://dx.doi.org/10.21236/ada613187.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
7

Wang, Paul C. A Partnership Training Program: Studying Targeted Drug Delivery Using Nanoparticles in Breast Cancer Diagnosis and Therapy. Fort Belvoir, VA: Defense Technical Information Center, October 2012. http://dx.doi.org/10.21236/ada568802.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
8

Wang, Paul C. A Partnership Training Program: Studying Targeted Drug Delivery Using Nanoparticles in Breast Cancer Diagnosis and Therapy. Fort Belvoir, VA: Defense Technical Information Center, October 2013. http://dx.doi.org/10.21236/ada597692.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
9

Green, Jeffrey E., and Kristin K. Deeb. Cross Species Identification and Functional Analysis of MicroRNAs in Mammary Tumorigenesis: Potential Targets for Detection, Diagnosis and Therapy. Fort Belvoir, VA: Defense Technical Information Center, July 2007. http://dx.doi.org/10.21236/ada473885.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
10

Zhenni, Mu, Le Lei, Shen Sinan, and Tang Li. Effectiveness of integrated Chinese herbal medicine Shoutai Pill and Western medicine in the treatment of recurrent pregnancy loss: A protocol for systematic review and meta-analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, October 2021. http://dx.doi.org/10.37766/inplasy2021.10.0062.

Повний текст джерела
Анотація:
Review question / Objective: We provide a protocol to evaluate the efficacy of integrated Shoutai Pill and Western medicine to update the evaluation for the best available and security treatment for recurrent pregnancy loss(RPL). Condition being studied: Recurrent pregnancy loss (RPL) is a distinct disorder defined by two or more consecutive pregnancy failures before 20 gestational weeks infertile couples. The incidence of this disease accounts for about 1%-5% of women of reproductive age and seriously affects their physical and psychological health. At present, the known etiology of this disease mainly includes abnormal anatomic structures, genetic abnormality, endocrine disorders, prethrombotic status, abnormal immune function, infection, etc. Excluding the above factors, approximately 40-50% of RPL remain unexplained, known as unexplained recurrent pregnancy loss (URPL). At present, the main therapeutic methods of RPL are surgical therapy, preimplantation genetic diagnosis (PGD), hormone therapy, anti-infection therapy, anticoagulation, and immunoregulatory therapy, etc. However, there is no effective treatment has been identified for URPL. Therefore, we still need to investigate effective treatments to reduce pregnancy losses and maintain successful pregnancy preservation in these patients.
Стилі APA, Harvard, Vancouver, ISO та ін.
Також вас можуть зацікавити розширені добірки на тему "Diagnosis/Therapy" для конкретних типів джерел:
Статті в журналах Дисертації Книги
Ми пропонуємо знижки на всі преміум-плани для авторів, чиї праці увійшли до тематичних добірок літератури. Зв'яжіться з нами, щоб отримати унікальний промокод!

До бібліографії